title: Resolution of choroidal neovascularization secondary to punctate inner choroidopathy (PIC) with intravitreal anti-VEGF agents: a case series.
abstract: Case series of four patients with CNVM secondary to PIC treated solely with anti VEGF in three cases and in combination with PDT in the other. This series reveals long term follow up (3 months to 28 months) which is currently not described in the literature.
authors.affiliation: Wirral University Hospital Trust. simranmangat36@hotmail.com
authors.forename: Simran S
authors.initials: SS
authors.lastname: Mangat
authors.forename: B
authors.initials: B
authors.lastname: Ramasamy
authors.forename: Som
authors.initials: S
authors.lastname: Prasad
authors.forename: Gavin
authors.initials: G
authors.lastname: Walters
authors.forename: Moin
authors.initials: M
authors.lastname: Mohammed
authors.forename: Martin
authors.initials: M
authors.lastname: Mckibbin
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D015862:Choroid Diseases / Q000150:complications / Q000503:physiopathology; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D003131:Combined Modality Therapy; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D033401:Microscopy, Acoustic; D008875:Middle Aged; D010778:Photochemotherapy; D000069579:Ranibizumab; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab